Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline (Q37351830)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 1996

Language	Label	Description	Also known as
English	Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline	scientific article published on February 1996

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline (English)

1 reference

Europe PubMed Central

19 August 2017

8

object named as

P Corvol

1 reference

Europe PubMed Central

19 August 2017

4

object named as

T T Guyene

1 reference

Europe PubMed Central

19 August 2017

author name string

M Azizi

1

1 reference

Europe PubMed Central

19 August 2017

A Rousseau

2

1 reference

Europe PubMed Central

19 August 2017

E Ezan

3

1 reference

Europe PubMed Central

19 August 2017

S Michelet

5

1 reference

Europe PubMed Central

19 August 2017

J M Grognet

6

1 reference

Europe PubMed Central

19 August 2017

M Lenfant

7

1 reference

Europe PubMed Central

19 August 2017

J Ménard

9

1 reference

Europe PubMed Central

19 August 2017

language of work or name

0 references

publication date

1 February 1996

1 reference

Europe PubMed Central

19 August 2017

Journal of Clinical Investigation

1 reference

Europe PubMed Central

19 August 2017

97

1 reference

Europe PubMed Central

19 August 2017

3

1 reference

Europe PubMed Central

19 August 2017

839-844

1 reference

Europe PubMed Central

19 August 2017

The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II). Studies with bradykinin and other natural peptides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

The broad substrate specificity of human angiotensin I converting enzyme

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

Involvement of thymosin beta 4 and endoproteinase Asp-N in the biosynthesis of the tetrapeptide AcSerAspLysPro a regulator of the hematopoietic system

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

Enalapril-associated anemia in renal transplant recipients treated for hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

The two homologous domains of human angiotensin I-converting enzyme are both catalytically active

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

6 September 2017

PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

14 September 2017

Calcium: its modulation in liver by cross-talk between the actions of glucagon and calcium-mobilizing agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

28 September 2017

Worsening of anemia induced by long-term use of captopril in hemodialysis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

28 September 2017

Distribution of a negative regulator of haematopoietic stem cell proliferation (AcSDKP) and thymosin beta 4 in mouse tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

28 September 2017

Captopril inhibits proliferation of human lung fibroblasts in culture: a potential antifibrotic mechanism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

26 June 2018

Captopril reduces collagen and mast cell accumulation in irradiated rat lung

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

26 June 2018

Amelioration of chemotherapy-induced toxicity by cotreatment with AcSDKP, a tetrapeptide inhibitor of hematopoietic stem cell proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

26 June 2018

Effect of losartan on haematology and haemorheology in elderly patients with essential hypertension: a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

2 September 2018

Exchangeable sodium in DOC-salt and post-DOC-salt hypertension in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=507123

5 November 2018

In vitro renin inhibition to prevent generation of angiotensins during determination of angiotensin I and II

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AcSDKP, an inhibitor of CFU-S proliferation, is synthesized in mice under steady-state conditions and secreted by bone marrow in long-term culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo effect of the tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of angiotensin II generation during converting enzyme inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenide) on the growth of human CD34+ subpopulations in response to growth factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radioprotective effect of captopril on the mouse jejunal mucosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low temperature sustains inhibition of angiotensin-converting-enzyme activity in serum from patients taking captopril

1 reference

https://pubmed.ncbi.nlm.nih.gov/8609242

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1172/JCI118484

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37351830&oldid=2117457588"